About Lyra Medical

About company

Lyra Medical develops a new, safer way to implant an organ support mechanism in women suffering from pelvic organ prolapse (POP). Lyra Medical LTD’s Self-Retaining Support (SRS) technology is presently being applied in the flagship Lyra system for anterior vaginal wall, Apex and uterine prolapse. The support platform may be applicable in other pelvic organ disorder conditions, such as rectocele and urinary incontinence, as well as other clinical areas, such as hernias. In all these areas, there is an acute need for therapeutic solutions that deliver exceptional safety and long-term efficacy. The company has a robust IP portfolio, including approved US and EU patents and pending applications in other regions.